Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
30m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
57m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Cognition Therapeutics Inc logo

Cognition Therapeutics Inc

About

Cognition Therapeutics Inc (NASDAQ:CGTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 7 2026
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
Mar 26 2026
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
Mar 23 2026
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results
Mar 17 2026
Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
Mar 2 2026
Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis

Financials

Revenue
$0
Market Cap
$77.56 M
EPS
-0.32

Community Chat

Ask AI

6ix6ixAIEvents